PRIP Scheme

 PRIP Scheme

Government of India is looking to formally launched PRIP (The Promotion of Research & Innovation in Pharma Medtech Sector.

• The Promotion of Research & Innovation in Pharma Medtech Sector.Announced August 17, 2023

• The objective of the PRIP scheme is to transform the Indian Pharma MedTech sector from cost-based competitiveness to innovation-based growth by strengthening the research infrastructure in the country.

• The aim of the scheme is to promote industry-academia linkage for R&D in priority areas and to inculcate the culture of quality research and nurture our pool of scientists.

• Rs 5,000 crore will be spent in five years (2024-28) under the PRIP scheme, and companies will be given incentives for research.

• The six focus areas of the scheme are 

  1.new chemical entities, including biological and phytopharmaceuticals;

  2. complex generics and biosimilars;

  3. precision medicines such as gene therapy and stem cells;

  4.medical devices using artificial intelligence and machine learning;

  5.orphan drugs;

  6.anti-microbial resistance.

• It focuses on two components:

  • Strengthening research infrastructure through Centres of Excellence (CoE) in the seven existing National Institutes of Pharmaceutical Education and Research (NIPERs), Institutes of national importance at a tentative cost of Rs. 700 crore over a period of five years. 

  • Government engagement with nine established pharmaceutical companies with an outlay of Rs. 125 crores over five years, an aid of Rs. 100 crores to 30 research projects on high-potential products and funding to 125 research projects among startups.

  • NOTE-Biosimilars are biological products that are used to treat a variety of diseases and medical conditions, including cancer, autoimmune disorders, and chronic diseases.